Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03066063 · ClinicalTrials.gov registry record
A New Approach to Vision Therapy Based on Naturalistic 3-D Computer Gaming
A clinical trial of Amblyopia and Ocular Motility Disorders, sponsored by Barron Associates.
- Completed
- Registry status
- 92
- Enrollment target
- 1
- Study location
NCT03066063 is a study of Amblyopia and Ocular Motility Disorders that has completed, run by Barron Associates. The registered enrollment target is 92 participants, below the 162-participant average among 24 other Amblyopia trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03066063, a study of Amblyopia and Ocular Motility Disorders, has completed, sponsored by Barron Associates.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The research team will execute two concurrent studies within a common framework. The first will compare iCare to standard of care occlusion therapy (patching) for amblyopia in patients ages 4 to 18 (inclusive). The second will compare iCare to a standard of care for home-based CI therapy (pencil pushups) for convergence insufficiency patients ages 8 to 18 (inclusive). In the context of this study, the term iCare refers to either the amblyopia or CI video game module as appropriate for the respective study group.
Conditions Studied
Interventions
- DEVICE iCare
- BEHAVIORAL Amblyopia standard of Care
- BEHAVIORAL CI standard of Care
Study Locations (1)
Tennessee
- Southern College of Optometry - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2022-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03066063
The ClinicalTrials.gov registry entry for NCT03066063 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 162-participant average among 24 other Amblyopia trials with a reported enrollment target (43% lower). The listed sponsor is Barron Associates, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Amblyopia appearing as the primary indexed condition, and to 3 interventions - of which iCare is the first listed.
NCT03066063 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT03066063 about?
NCT03066063 is a clinical study titled "A New Approach to Vision Therapy Based on Naturalistic 3-D Computer Gaming". The research team will execute two concurrent studies within a common framework. The first will compare iCare to standard of care occlusion therapy (patching) for amblyopia in patients ages 4 to 18 (inclusive). The second will compare iCare to a standard of care for home-based CI therapy (pencil pus...
What is the current status of trial NCT03066063?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2019-05-07. Estimated completion is 2022-02-28.
What conditions does trial NCT03066063 study?
This clinical trial studies the following conditions: Amblyopia, Ocular Motility Disorders.
What interventions are being tested in trial NCT03066063?
The interventions under investigation include: iCare (DEVICE), Amblyopia standard of Care (BEHAVIORAL), CI standard of Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03066063?
This trial is sponsored by Barron Associates, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03066063 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Noninvasive Brain Stimulation in Adult Amblyopia
RECRUITING · NA
-
OCT Eccentric Fixation and Amblyopia in Children
RECRUITING · NA
-
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
RECRUITING
-
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.